Stay updated with breaking news from Erical mayer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nancy U. Lin, MD, provides clinical insights on the treatment of patients with breast cancer brain metastases and discusses the advantages and disadvantages of systemic therapy vs radiation therapy for this population. ....
Sarah Sammons, MD, discusses the evolving role of CDK4/6 inhibitors in hormone receptor–positive breast cancer, the future of antibody-drug conjugates in triple-negative breast cancer, and the importance of educating patients about their available treatment options so they can share in the decision-making process. ....
Endocrine therapy remains the mainstay of treatment in metastatic breast cancer. Dr Erica Mayer discusses adding targeted agents as clinicians strive to improve therapeutic options and efficacy. ....
Continuing CDK4/6 inhibitor therapy and switching ET after progression does not improve PFS vs switching ET alone in HR+, HER2- metastatic breast cancer. ....
A novel smartphone app that combines problem-solving and behavioral activation appears to offer a way of helping breast cancer survivors reduce their fear of cancer recurrence. ....